Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelika Ullrich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2021
Three Methods for the Solution Phase Synthesis of Cyclic PeptidesAngelika Ullrich, Lukas Junk, Uli Kazmaier
The Journal of Organic Chemistry|May 11, 2012
Development of catalysts for the stereoselective hydrogenation of α,β-unsaturated ketonesFrauke Maurer, Volker Huch, Angelika Ullrich, et al.
Beilstein Journal of Organic Chemistry|December 5, 2012
Synthetic studies towards bottromycinStefanie Ackermann, Hans-Georg Lerchen, Dieter Häbich, et al.
Oncotarget|November 5, 2017
The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cellsRebecca Schwenk, Tanja Stehning, Iris Bischoff, et al.
Chemistry & Biology|March 27, 2010
Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004Yi Chai, Dominik Pistorius, Angelika Ullrich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2013
Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivoVerena K Kretzschmann, Donata Gellrich, Angelika Ullrich, et al.
Angewandte Chemie (International Ed. in English)|May 12, 2009
Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformisAngelika Ullrich, Yi Chai, Dominik Pistorius, et al.
Plos One|May 23, 2012
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapyJennifer Herrmann, Yasser A Elnakady, Romina M Wiedmann, et al.
Molecular Biosystems|June 23, 2012
Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopyJürgen Eirich, Jens L Burkhart, Angelika Ullrich, et al.
Journal of Natural Products|January 21, 2014
Simplified pretubulysin derivatives and their biological effects on cancer cellsRebekka Kubisch, Matthias von Gamm, Simone Braig, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2021
Three Methods for the Solution Phase Synthesis of Cyclic PeptidesAngelika Ullrich, Lukas Junk, Uli Kazmaier
The Journal of Organic Chemistry|May 11, 2012
Development of catalysts for the stereoselective hydrogenation of α,β-unsaturated ketonesFrauke Maurer, Volker Huch, Angelika Ullrich, et al.
Beilstein Journal of Organic Chemistry|December 5, 2012
Synthetic studies towards bottromycinStefanie Ackermann, Hans-Georg Lerchen, Dieter Häbich, et al.
Oncotarget|November 5, 2017
The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cellsRebecca Schwenk, Tanja Stehning, Iris Bischoff, et al.
Chemistry & Biology|March 27, 2010
Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004Yi Chai, Dominik Pistorius, Angelika Ullrich, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2013
Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivoVerena K Kretzschmann, Donata Gellrich, Angelika Ullrich, et al.
Angewandte Chemie (International Ed. in English)|May 12, 2009
Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformisAngelika Ullrich, Yi Chai, Dominik Pistorius, et al.
Plos One|May 23, 2012
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapyJennifer Herrmann, Yasser A Elnakady, Romina M Wiedmann, et al.
Molecular Biosystems|June 23, 2012
Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopyJürgen Eirich, Jens L Burkhart, Angelika Ullrich, et al.
Journal of Natural Products|January 21, 2014
Simplified pretubulysin derivatives and their biological effects on cancer cellsRebekka Kubisch, Matthias von Gamm, Simone Braig, et al.
Pageof 2